NYLIM WMC Value Class I holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
NYLIM WMC Value Class I MUBFX
- NAV / 1-Day Return 37.61 / +0.62 %
- Total Assets 871.4M
-
Adj. Expense Ratio
0.700%
- Expense Ratio 0.700%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 1M
- Status Open
- TTM Yield 1.40%
- Turnover 43%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0
Morningstar’s Analysis MUBFX
Will MUBFX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 27.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Microsoft Corp | 6.77 | 62M | Technology |
JPMorgan Chase & Co | 3.53 | 32M | Financial Services |
Merck & Co Inc | 2.78 | 25M | Healthcare |
Johnson & Johnson | 2.70 | 25M | Healthcare |
Cisco Systems Inc | 2.04 | 19M | Technology |
UnitedHealth Group Inc | 2.01 | 18M | Healthcare |
Elevance Health Inc | 1.82 | 17M | Healthcare |
Intercontinental Exchange Inc | 1.80 | 16M | Financial Services |
Gilead Sciences Inc | 1.80 | 16M | Healthcare |
Pfizer Inc | 1.77 | 16M | Healthcare |